BioRestorative Therapies (BRTX) Receivables - Net (2016 - 2025)
Historic Receivables - Net for BioRestorative Therapies (BRTX) over the last 11 years, with Q3 2025 value amounting to $13400.0.
- BioRestorative Therapies' Receivables - Net fell 9187.88% to $13400.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $13400.0, marking a year-over-year decrease of 9187.88%. This contributed to the annual value of $188400.0 for FY2024, which is 87616.58% up from last year.
- BioRestorative Therapies' Receivables - Net amounted to $13400.0 in Q3 2025, which was down 9187.88% from $15000.0 recorded in Q2 2025.
- BioRestorative Therapies' 5-year Receivables - Net high stood at $188400.0 for Q4 2024, and its period low was $5000.0 during Q4 2021.
- For the 5-year period, BioRestorative Therapies' Receivables - Net averaged around $37252.6, with its median value being $18000.0 (2021).
- In the last 5 years, BioRestorative Therapies' Receivables - Net soared by 87616.58% in 2024 and then crashed by 9187.88% in 2025.
- Quarter analysis of 5 years shows BioRestorative Therapies' Receivables - Net stood at $5000.0 in 2021, then soared by 220.0% to $16000.0 in 2022, then rose by 20.62% to $19300.0 in 2023, then skyrocketed by 876.17% to $188400.0 in 2024, then crashed by 92.89% to $13400.0 in 2025.
- Its Receivables - Net stands at $13400.0 for Q3 2025, versus $15000.0 for Q2 2025 and $25000.0 for Q1 2025.